Savient visits FDA re Krystexxa manufacturing changes; Schering Plough plans long goodbye for 160 plant workers;

> Savient Pharmaceuticals is on the FDA's calendar today following last year's rejection of gout treatment Krystexxa due to concerns over manufacturing changes. Story

> Schering Plough will eliminate 160 jobs on a voluntary basis over three years at its west Cork manufacturing plant. Article 

> Rio de Janeiro drugmaker Mantecorp has adopted Mitsubishi automation controllers and the open-technology CC-Link industrial communication network in a renovation of two facilities totaling 350,000 square meters. News

> DHL has teamed with frozen transport and packaging systems provider CryoPort to offer drugmakers speedy access to the latter's CryoPort Express Shipper and preferred DHL shipping rates. CryoPort release

> Advaxis has begun a manufacturing program for clinical quantities of human-grade ADXS31-164, a live Listeria vaccine that targets Her2 tumors. Advaxis release